Login
Toggle sidebar

Lint: nasopharyngeal-cancer-staging

nasopharyngeal-cancer-staging
Strong List Colon Position
error

"T4: any one or more of the following tumour extension/involvement:"

Line 23:4 · When enboldening an intro, the colon should not be bold. '<strong>T4:</strong> any'
Optional Plurals
error

"unilateral cervical lymph node(s), and/or"

Line 42:34 · Do not use plurals in parentheses such as in 'node(s)'.

"unilateral or bilateral retropharyngeal lymph node(s)"

Line 43:54 · Do not use plurals in parentheses such as in 'node(s)'.
Acronyms
warning

"Nasopharyngeal cancer staging refers to TNM staging of malignant tumours of the nasopharynx. The vast majority of applicable tumours are nasopharyngeal carcinomas, but other epithelial malignancies of the nasopharynx are included, such as minor salivary gland tumours. The following article reflects the 9th version published by the American Joint Committee on Cancer(AJCC)/Union for International Cancer Control (UICC), which is used for staging starting 1 January 2025 1."

Line 1:64 · 'TNM' has no definition. Spell it out if it's unfamiliar to the audience.

"Nasopharyngeal cancer staging refers to TNM staging of malignant tumours of the nasopharynx. The vast majority of applicable tumours are nasopharyngeal carcinomas, but other epithelial malignancies of the nasopharynx are included, such as minor salivary gland tumours. The following article reflects the 9th version published by the American Joint Committee on Cancer(AJCC)/Union for International Cancer Control (UICC), which is used for staging starting 1 January 2025 1."

Line 1:428 · 'AJCC' has no definition. Spell it out if it's unfamiliar to the audience.

"Nasopharyngeal cancer staging refers to TNM staging of malignant tumours of the nasopharynx. The vast majority of applicable tumours are nasopharyngeal carcinomas, but other epithelial malignancies of the nasopharynx are included, such as minor salivary gland tumours. The following article reflects the 9th version published by the American Joint Committee on Cancer(AJCC)/Union for International Cancer Control (UICC), which is used for staging starting 1 January 2025 1."

Line 1:474 · 'UICC' has no definition. Spell it out if it's unfamiliar to the audience.

"TX: primary tumour cannot be assessed"

Line 4:16 · 'TX' has no definition. Spell it out if it's unfamiliar to the audience.

"T0: no evidence of primary tumour, but EBV-positive nodal involvement"

Line 5:64 · 'EBV' has no definition. Spell it out if it's unfamiliar to the audience.

"*Though it is not explicitly defined in the AJCC manual, "pterygoid structures" include medial/lateral pterygoid plates, pterygomaxillary fissure, and pterygopalatine fossa according to articles that formed the basis of the 8th edition criteria 2."

Line 34:48 · 'AJCC' has no definition. Spell it out if it's unfamiliar to the audience.

"NX: nodes cannot be assessed"

Line 37:16 · 'NX' has no definition. Spell it out if it's unfamiliar to the audience.

"Compared to the 8th version of the AJCC/UICC TNM staging system, T categories were unchanged, N categories added advanced extranodal extension as an N3 criterion, and M categories subdivided M1 into M1a and M1b 1. Stage groups were also updated to merge stage I and II, down-classify stage III and IVA to II and III, subdivide stages I and IV, and move M1 exclusively to stage IV."

Line 101:50 · 'AJCC' has no definition. Spell it out if it's unfamiliar to the audience.

"Compared to the 8th version of the AJCC/UICC TNM staging system, T categories were unchanged, N categories added advanced extranodal extension as an N3 criterion, and M categories subdivided M1 into M1a and M1b 1. Stage groups were also updated to merge stage I and II, down-classify stage III and IVA to II and III, subdivide stages I and IV, and move M1 exclusively to stage IV."

Line 101:55 · 'UICC' has no definition. Spell it out if it's unfamiliar to the audience.

"Compared to the 8th version of the AJCC/UICC TNM staging system, T categories were unchanged, N categories added advanced extranodal extension as an N3 criterion, and M categories subdivided M1 into M1a and M1b 1. Stage groups were also updated to merge stage I and II, down-classify stage III and IVA to II and III, subdivide stages I and IV, and move M1 exclusively to stage IV."

Line 101:60 · 'TNM' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Case
warning

"Primary tumour (T)"

Line 2:5 · 'Primary tumour (T)' should use sentence-style capitalization.

"Regional lymph node (N)"

Line 35:5 · 'Regional lymph node (N)' should use sentence-style capitalization.

"Distant metastases (M)"

Line 56:5 · 'Distant metastases (M)' should use sentence-style capitalization.
List Caps
warning

"Tis: carcinoma in situ"

Line 6:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"M1a: ≤3 distant metastatic lesions"

Line 59:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"M1b: >3 distant metastatic lesions"

Line 60:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Stage 0"

Line 66:12 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Tis, N0, M0"

Line 67:12 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Stage IA"

Line 70:12 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Stage IB"

Line 74:12 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Stage IVA"

Line 92:12 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Stage IVB"

Line 96:12 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Primary tumour (T)"

Line 2:1 · "Primary tumour (T)" is not a recognised heading for this article type.

"Regional lymph node (N)"

Line 35:1 · "Regional lymph node (N)" is not a recognised heading for this article type.

"Distant metastases (M)"

Line 56:1 · "Distant metastases (M)" is not a recognised heading for this article type.

"Stage groupings"

Line 63:1 · "Stage groupings" is not a recognised heading for this article type.

"Changes from prior versions"

Line 100:1 · "Changes from prior versions" is not a recognised heading for this article type.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0